Jong-Won Chung Selected Research

Intracranial Arteriosclerosis (Cerebral Atherosclerosis)

1/2021	Pre-Admission CHADS2 and CHA2DS2-VASc Scores on Early Neurological Worsening.
1/2021	Role of the RNF213 Variant in Vascular Outcomes in Patients With Intracranial Atherosclerosis.
1/2020	Intensive Statin Treatment in Acute Ischaemic Stroke Patients with Intracranial Atherosclerosis: a High-Resolution Magnetic Resonance Imaging study (STAMINA-MRI Study).
1/2019	Characteristics and Factors for Short-Term Functional Outcome in Stroke Patients With Atrial Fibrillation, Nationwide Retrospective Cohort Study.
1/2016	Previous Statin Use and High-Resolution Magnetic Resonance Imaging Characteristics of Intracranial Atherosclerotic Plaque: The Intensive Statin Treatment in Acute Ischemic Stroke Patients With Intracranial Atherosclerosis Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jong-Won Chung Research Topics

Disease

41	Stroke (Strokes) 01/2022 - 01/2013
23	Ischemic Stroke 01/2022 - 01/2013
8	Neoplasms (Cancer) 01/2022 - 01/2016
8	Atrial Fibrillation 01/2022 - 01/2016
6	Hemorrhage 01/2022 - 02/2014
6	Atherosclerosis 01/2020 - 02/2014
5	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 01/2021 - 01/2016
4	Moyamoya Disease (Moya-Moya Disease) 01/2021 - 12/2016
4	Infarction (Infarctions) 01/2021 - 01/2016
3	Atherosclerotic Plaque (Atheroma) 01/2020 - 02/2014
2	Cerebral Infarction 01/2021 - 01/2015
2	Pathologic Constriction (Stenosis) 01/2020 - 01/2020
2	Embolic Stroke 11/2017 - 01/2017
1	Transient Ischemic Attack 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Headache (Headaches) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Chronic Hepatitis B 01/2022
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2020
1	Obesity 01/2020
1	Thrombosis (Thrombus) 01/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Embolism (Embolus) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2019
1	Hypertension (High Blood Pressure) 11/2019
1	Vascular Remodeling 10/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018
1	Adenocarcinoma 01/2018
1	Thrombophilia 01/2017
1	Inflammation (Inflammations) 01/2017
1	Intracranial Embolism 01/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017
1	Hematoma 02/2014

Drug/Important Bio-Agent (IBA)

7	fibrin fragment D (D-dimer)IBA 01/2022 - 01/2016
7	AnticoagulantsIBA 12/2021 - 01/2017
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2016
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2016
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021 - 01/2017
3	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2017 - 03/2016
2	HomocysteineIBA 01/2022 - 03/2016
2	Cell-Free Nucleic AcidsIBA 12/2021 - 10/2019
2	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 11/2017
2	Phenobarbital (Luminal)FDA Link 01/2020 - 11/2018
2	CholesterolIBA 12/2019 - 02/2019
2	EndostatinsIBA 12/2016 - 03/2016
2	AlbuminsIBA 03/2016 - 01/2015
2	danaparoid (Orgaran)FDA Link 09/2014 - 08/2014
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Dipyridamole (Persantine)FDA LinkGeneric 01/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2021
1	Factor Xa (Coagulation Factor Xa)IBA 12/2021
1	Factor Xa InhibitorsIBA 12/2021
1	Enoxaparin (Lovenox)FDA LinkGeneric 12/2021
1	A-factor (Streptomyces)IBA 12/2021
1	Cilostazol (Pletal)FDA LinkGeneric 01/2021
1	thiamine triphosphorate (TTP)IBA 12/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Thrombin FDA Link 01/2020
1	TroponinIBA 01/2020
1	Troponin IIBA 01/2020
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 11/2019
1	Nucleosomes (Nucleosome)IBA 10/2019
1	DNA (Deoxyribonucleic Acid)IBA 10/2019
1	LDL CholesterolIBA 02/2019
1	Nonesterified Fatty Acids (NEFA)IBA 11/2017
1	Particulate MatterIBA 01/2017
1	Air Pollutants (Pollutants, Air)IBA 01/2017
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2016
1	NitritesIBA 12/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2016
1	Caveolin 1IBA 12/2016
1	NitratesIBA 12/2016
1	CytokinesIBA 12/2016
1	C-Reactive ProteinIBA 03/2016
1	Lipoprotein(a)IBA 03/2016
1	ResistinIBA 03/2016
1	E-SelectinIBA 03/2016
1	AdiponectinIBA 03/2016
1	CreatinineIBA 03/2016
1	Heparin (Liquaemin)FDA LinkGeneric 01/2016
1	Thromboplastin (Tissue Factor)IBA 01/2016
1	Cell Adhesion MoleculesIBA 01/2016
1	CalciumIBA 01/2015
1	LipidsIBA 02/2014
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2013
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 04/2010

Therapy/Procedure

22	Therapeutics 01/2022 - 01/2017
5	Thrombectomy 01/2022 - 01/2017
2	Aftercare (After-Treatment) 01/2021 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2019
1	Intravenous Injections 01/2022
1	Punctures 01/2021
1	Injections 01/2021
1	Radiotherapy 01/2020
1	Secondary Prevention 09/2019
1	Thrombolytic Therapy 09/2014